Phenylmethylsulfonyl Fluoride
Description
Product Description
Phenylmethylsulfonyl Fluoride
Application Notes
Phenylmethylsulfonyl fluoride ,inhibits serine proteases such as trypsin and chymotrypsin. Also inhibits cysteine proteases (reversible by reduced thiols) and mammalian acetylcholinesterase
Usage Statement
Research Use Only (RUO). Ready for CE IVD labeling of clinical applications.
Key Applications
Inhibition
Specifications
| SKU | 02195381-CF |
| Alternate Names | PMSF; Phenylmethanesulfonyl fluoride; a-Toluenesulfonyl fluoride |
| Application Notes | Phenylmethylsulfonyl fluoride ,inhibits serine proteases such as trypsin and chymotrypsin. Also inhibits cysteine proteases (reversible by reduced thiols) and mammalian acetylcholinesterase |
| Beilstein Registry Number | 2088311 |
| Biochemical Physiological Actions | Administration of PMSF produces analgesia unrelated to its anticholinesterase effect, and prolongs the analagesic effect of centrally administered β-endorphin. |
| EC Number | 206-350-2 |
| Applications | Inhibition |
| MDL # | MFCD00007424 |
| Molecular Formula | C7H7FO2S |
| Molecular Weight | 174.189 g/mol |
| Personal Protective Equipment | Eyeshields, Faceshields, full-face particle respirator , Gloves, respirator cartridge, respirator filter |
| Physical Appearance | White to off white needle crystals |
| Product Families Description | Phenylmethylsulfonyl fluoride |
| Product Overview | Phenylmethylsulfonyl Fluoride |
| RTECS Number | XT8040000 |
| Safety Symbol | GHS05, GHS06 |
| Storage and Handling | Store at +4 °C. |
| Typical Working Concentration | Recommended concentration is 15 to 175 ug/mL. |
| Usage Statement | Research Use Only (RUO). Ready for CE IVD labeling of clinical applications. |